159 related articles for article (PubMed ID: 31626145)
1. Outcomes of pathologically localized high-grade prostate cancer treated with radical prostatectomy.
Heo JE; Park JS; Lee JS; Kim J; Jang WS; Rha KH; Choi YD; Hong SJ; Ham WS
Medicine (Baltimore); 2019 Oct; 98(42):e17627. PubMed ID: 31626145
[TBL] [Abstract][Full Text] [Related]
2. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.
Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
Eur Urol; 2017 Jun; 71(6):907-912. PubMed ID: 27876305
[TBL] [Abstract][Full Text] [Related]
3. Radical prostatectomy in Denmark: Survival analysis and temporal trends in clinicopathological parameters with up to 20 years of follow-up.
Heering M; Berg KD; Brasso K; Iversen P; Røder MA
Surg Oncol; 2017 Mar; 26(1):21-27. PubMed ID: 28317581
[TBL] [Abstract][Full Text] [Related]
4. Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.
Özsoy M; D'Andrea D; Moschini M; Foerster B; Abufaraj M; Mathieu R; Briganti A; Karakiewicz PI; Roupret M; Seitz C; Czech AK; Susani M; Shariat SF
Urol Oncol; 2018 Apr; 36(4):158.e1-158.e6. PubMed ID: 29288003
[TBL] [Abstract][Full Text] [Related]
5. Postoperative biochemical recurrence of pathologically localized high-grade prostate cancer in adjuvant treatment-naïve patients.
Heo JE; Park JS; Lee JS; Kim J; Jang WS; Cho NH; Rha KH; Choi YD; Hong SJ; Ham WS
J Cancer Res Clin Oncol; 2020 Jan; 146(1):221-227. PubMed ID: 31612318
[TBL] [Abstract][Full Text] [Related]
6. Effect of Preoperative Risk Group Stratification on Oncologic Outcomes of Patients with Adverse Pathologic Findings at Radical Prostatectomy.
Jang WS; Kim LH; Yoon CY; Rha KH; Choi YD; Hong SJ; Ham WS
PLoS One; 2016; 11(10):e0164497. PubMed ID: 27716842
[TBL] [Abstract][Full Text] [Related]
7. Differential prognostic impact of different Gleason patterns in grade group 4 in radical prostatectomy specimens.
Mori K; Sharma V; Comperat EM; Sato S; Laukhtina E; Schuettfort VM; Pradere B; Parizi MK; Karakiewicz PI; Egawa S; Tilki D; Boorjian SA; Shariat SF
Eur J Surg Oncol; 2021 May; 47(5):1172-1178. PubMed ID: 33371950
[TBL] [Abstract][Full Text] [Related]
8. The prognostic impact of downgrading and upgrading from biopsy to radical prostatectomy among men with Gleason score 7 prostate cancer.
Jang WS; Koh DH; Kim J; Lee JS; Chung DY; Ham WS; Rha KH; Choi YD
Prostate; 2019 Dec; 79(16):1805-1810. PubMed ID: 31483062
[TBL] [Abstract][Full Text] [Related]
9. Impact of surgical margin status on prostate-cancer-specific mortality.
Chalfin HJ; Dinizo M; Trock BJ; Feng Z; Partin AW; Walsh PC; Humphreys E; Han M
BJU Int; 2012 Dec; 110(11):1684-9. PubMed ID: 22788795
[TBL] [Abstract][Full Text] [Related]
10. Interval to biochemical recurrence following radical prostatectomy does not affect survival in men with low-risk prostate cancer.
Bolton DM; Ta A; Bagnato M; Muller D; Lawrentschuk NL; Severi G; Syme RR; Giles GG
World J Urol; 2014 Apr; 32(2):431-5. PubMed ID: 23824175
[TBL] [Abstract][Full Text] [Related]
11. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ
Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759
[TBL] [Abstract][Full Text] [Related]
12. Long-term cancer control outcomes in patients with biochemical recurrence and the impact of time from radical prostatectomy to biochemical recurrence.
Pompe RS; Gild P; Karakiewicz PI; Bock LP; Schlomm T; Steuber T; Graefen M; Huland H; Tian Z; Tilki D
Prostate; 2018 Jun; 78(9):676-681. PubMed ID: 29570821
[TBL] [Abstract][Full Text] [Related]
13. Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
Lughezzani G; Gallina A; Larcher A; Briganti A; Capitanio U; Suardi N; Lista G; Abrate A; Sangalli MN; Buffi N; Cestari A; Guazzoni G; Rigatti P; Montorsi F
BJU Int; 2013 May; 111(5):723-30. PubMed ID: 22487441
[TBL] [Abstract][Full Text] [Related]
14. The prognostic role of tertiary Gleason pattern 5 in a contemporary grading system for prostate cancer.
Jang WS; Yoon CY; Kim MS; Kang DH; Kang YJ; Jeong WS; Abalajon MJ; Ham WS; Choi YD
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):93-98. PubMed ID: 27845330
[TBL] [Abstract][Full Text] [Related]
15. Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy.
Fajkovic H; Mathieu R; Lucca I; Hiess M; Hübner N; Al Hussein Al Awamlh B; Lee R; Briganti A; Karakiewicz P; Lotan Y; Roupret M; Rink M; Kluth L; Loidl W; Seitz C; Klatte T; Kramer G; Susani M; Shariat SF
Urol Oncol; 2016 May; 34(5):233.e1-6. PubMed ID: 26973136
[TBL] [Abstract][Full Text] [Related]
16. Short (≤ 1 mm) positive surgical margin and risk of biochemical recurrence after radical prostatectomy.
Shikanov S; Marchetti P; Desai V; Razmaria A; Antic T; Al-Ahmadie H; Zagaja G; Eggener S; Brendler C; Shalhav A
BJU Int; 2013 Apr; 111(4):559-63. PubMed ID: 22759270
[TBL] [Abstract][Full Text] [Related]
17. The New Prostate Cancer Grading System Does Not Improve Prediction of Clinical Recurrence After Radical Prostatectomy: Results of a Large, Two-Center Validation Study.
Dell'Oglio P; Karnes RJ; Gandaglia G; Fossati N; Stabile A; Moschini M; Cucchiara V; Zaffuto E; Karakiewicz PI; Suardi N; Montorsi F; Briganti A
Prostate; 2017 Feb; 77(3):263-273. PubMed ID: 27753114
[TBL] [Abstract][Full Text] [Related]
18. The CPC Risk Calculator: A New App to Predict Prostate-specific Antigen Recurrence During Follow-up After Radical Prostatectomy.
Røder MA; Berg KD; Loft MD; Thomsen FB; Ferrari M; Kurbegovic S; Rytgaard HC; Gruschy L; Brasso K; Gerds TA; Kjær A; Brooks JD; Iversen P
Eur Urol Focus; 2018 Apr; 4(3):360-368. PubMed ID: 28753827
[TBL] [Abstract][Full Text] [Related]
19. Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies.
Briganti A; Joniau S; Gandaglia G; Cozzarini C; Sun M; Tombal B; Haustermans K; Hinkelbein W; Shariat SF; Karakiewicz PI; Montorsi F; Van Poppel H; Wiegel T
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):960-7. PubMed ID: 24351411
[TBL] [Abstract][Full Text] [Related]
20. Is More Always Better? An Assessment of the Impact of Lymph Node Yield on Outcome for Clinically Localized Prostate Cancer with Low/Intermediate Risk Pathology (pT2-3a/pN0) Managed with Prostatectomy Alone.
Seyedin SN; Mitchell DL; Mott SL; Russo JK; Tracy CR; Snow AN; Parkhurst JR; Smith MC; Buatti JM; Watkins JM
Pathol Oncol Res; 2019 Jan; 25(1):209-215. PubMed ID: 29079967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]